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Regarding “Chronic venous insufficiency is
associated with increased platelet and monocyte
activation and aggregation”
To the Editors:
We read with interest the above-named article by
Powell et al (J Vasc Surg 1999;30:844-53), which demon-
strated an underlying state of platelet activation in patients
with chronic venous insufficiency. As for systemic arterial
circulation, it is known that platelet aggregability and adhe-
sivity show a circadian pattern, with higher levels in the
morning.1 With a reduced endogenous fibrinolytic activi-
ty,2 such morning trombophilic status may concur in deter-
mining the higher incidence of both cardiovascular3 and
cerebrovascular4 accidents. Moreover, peripheral acute
arterial occlusion of the limbs is more likely to occur in the
morning, too.5 We do not know from Powell et al’s results
whether patients were measured for platelet-monocyte
aggregates always at the same hour or not. It could be
interesting, in fact, to verify whether a percentage of circu-
lating aggregates could show any temporal differences (eg,
comparing morning versus evening measurements in both
healthy and venous chronic insufficient subjects). It is
somewhat difficult to estimate, at the current level of
knowledge, the possible physiopathological role (if any) of
a circadian difference in platelet activation also in venous
disease. On one hand, however, a circadian variation with a
morning peak of occurrence has also been reported for pul-
monary thromboembolism.6 On the other hand, there
could be a potential for therapeutic applications. It has
been shown, in fact, that aspirin is more effective in reduc-
ing morning than evening myocardial infarctions,7 and it
also seems that thrombolysis efficacy may depend on the
time of infarction.8 A tailored therapeutic approach has
been suggested for cardiovascular diseases,9 and a deeper
knowledge of temporal patterns of all underlying factors
potentially leading to formation of thrombi could also be
interesting in the venous bloodstream as well.
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